MRNA COVID VACCINES
His grandfather died of pancreatic cancer: This Hyderabad startup founder is using AI to develop a personalised cancer vaccines
Hyderabad-based biotech startup PopVax, founded by Soham Sankaran, is developing AI-powered personalised cancer vaccines using mRNA technology. Inspired partly by his family's experience with pancreatic cancer, he aims to help the immune system identify and attack cancer cells using treatments designed around individual patients' tumour genetics.
- Go To Page 1
Our central mission must be patient-centric innovation: JP Nadda
J P Nadda urges industry to take discoveries ‘from bench to bedside’ as the FICCI–Lilly Bharat Life Sciences Award backs its inaugural cohort with ₹7 crore in grants
2026 Nobel Prize Predictions: From GLP-1 drugs and CAR-T therapy to gene editing, these breakthroughs could take centre stage
Predictions for the 2026 Nobel Prizes in science highlight significant contributions in areas like GLP-1 research and cancer therapies. Carl June is mentioned for his role in developing CAR-T cell therapy for cancer treatment. Researchers Emmanuel Mignot and Masashi Yanagisawa are noted for their work on orexin related to sleep regulation. Optical coherence tomography and lipid nanoparticle technology are also strong candidates for recognition.
Kiran Mazumdar-Shaw has a career lesson from 3 Nobel prize winners as AI forces layoffs and changes jobs across the world
Biocon chairperson Kiran Mazumdar-Shaw shared a message on persistence from three 2023 Nobel Prize winners as AI reshapes jobs and companies rethink their workforces. Her post highlighted the importance of finding reasons to keep going despite setbacks, a message that resonates with workers facing career uncertainty, layoffs and changing skill requirements.
Load More
